Centre for Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK
Aston Pharmacy School, Aston University School of Life and Health Sciences, Birmingham, UK.
BMJ Open. 2024 Jan 2;14(1):e071863. doi: 10.1136/bmjopen-2023-071863.
To establish research priorities which will support the development and delivery of community pharmacy initiatives for the management of skin conditions.
An iterative, multistage stakeholder consultation consisting of online survey, participant workshops and prioritisation meeting.
All data collection took place online with participants completing a survey (delivered via the JISC Online Survey platform, between July 2021 and January 2022) and participating in online workshops and meetings (hosted on Microsoft Teams between April and July 2022).
174 community pharmacists and pharmacy staff completed the online survey.53 participants participated in the exploratory workshops (19 community pharmacists, 4 non-pharmacist members of pharmacy staff and 30 members of the public). 4 healthcare professionals who were unable to attend a workshop participated in a one-to-one interview.29 participants from the workshops took part in the prioritisation meeting (5 pharmacists/pharmacy staff, 1 other healthcare professional and 23 members of the public).
Five broad areas of potential research need were identified in the online survey: (1) identifying and diagnosing skin conditions; (2) skin conditions in skin of colour; (3) when to refer skin conditions; (4) disease-specific concerns and (5) product-specific concerns.These were explored and refined in the workshops to establish 10 potential areas for research, which will support pharmacists in managing skin conditions. These were ranked in the prioritisation meeting. Among those prioritised were topics which consider how pharmacists work with other healthcare professionals to identify and manage skin conditions.
Survey responses and stakeholder workshops all recognised the potential for community pharmacists to play an active role in the management of common skin conditions. Future research may support this in the generation of resources for pharmacists, in encouraging public take-up of pharmacy services, and in evaluating the most effective provision for dealing with skin conditions.
确定研究重点，以支持开发和实施社区药房举措，以管理皮肤状况。
一个迭代的、多阶段的利益相关者咨询，包括在线调查、参与者研讨会和优先级会议。
所有数据收集都在网上进行，参与者完成了一项在线调查（通过 JISC 在线调查平台，于 2021 年 7 月至 2022 年 1 月之间进行）并参加了在线研讨会和会议（2022 年 4 月至 7 月期间在 Microsoft Teams 上进行）。
174 名社区药剂师和药剂师工作人员完成了在线调查。53 名参与者参加了探索性研讨会（19 名社区药剂师、4 名非药剂师药剂师工作人员和 30 名公众）。4 名无法参加研讨会的医疗保健专业人员参加了一对一访谈。29 名来自研讨会的参与者参加了优先级会议（5 名药剂师/药剂师工作人员、1 名其他医疗保健专业人员和 23 名公众）。
在线调查中确定了五个潜在研究领域：（1）识别和诊断皮肤状况；（2）皮肤色素沉着的皮肤状况；（3）何时转介皮肤状况；（4）特定疾病的关注；（5）特定产品的关注。这些在研讨会上进行了探讨和完善，以确定 10 个潜在的研究领域，这将支持药剂师管理皮肤状况。这些在优先级会议上进行了排名。在优先级较高的领域中，有一些考虑了药剂师如何与其他医疗保健专业人员合作来识别和管理皮肤状况的主题。
调查答复和利益相关者研讨会都认识到社区药剂师在管理常见皮肤状况方面发挥积极作用的潜力。未来的研究可能会在为药剂师生成资源、鼓励公众利用药店服务以及评估处理皮肤状况的最有效服务方面提供支持。
